340B Drug Pricing Program Annual Recertification
340B covered entities must annually recertify their eligibility to remain in the 340B Drug Pricing Program and continue purchasing covered outpatient drugs at discounted 340B prices.
Final
Issued by: Health Resources and Services Administration (HRSA)
Annual Recertification
340B covered entities must annually recertify their eligibility to remain in the 340B Drug Pricing Program and continue purchasing covered outpatient drugs at discounted 340B prices.
Advance email notifications with preliminary information about the recertification process are sent to the following contacts:
- Primary Contact
- Authorizing Official
Once the recertification period begins, the Authorizing Official only has access via their user accounts to perform recertification. The Authorizing Official will be required to log into the 340B OPAIS, update information as needed, and attest to the covered entity’s compliance with 340B Program requirements.
The covered entity must ensure the contacts listed in the 340B database are accurate at all times to receive all recertification notifications.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.